Scientific illustration and figure-creation software for researchers
BioRender sells a SaaS tool that lets scientists build publication-ready figures and graphics. Hiring tilts heavily toward sales, marketing and support rather than engineering, and pain points like renewal risk and expanding mid-market revenue suggest a company shifting from product-led adoption toward a structured revenue engine. A stack of Salesforce, Outreach, ZoomInfo and Zendesk alongside SCIM, Okta and OAuth 2.0 points to enterprise and institutional selling.
BioRender is a Toronto-based, privately held software company founded in 2017 that builds tools for creating science illustrations and communicating research visually. Its users are scientists and researchers, and the company also produces educational tutorials and field events for that audience. The product runs on React, Node.js, Express.js, MongoDB and Prisma on AWS, with Terraform, Cloudflare and Datadog supporting infrastructure. The company has 201–500 employees and hires in the United States, Ireland and Canada.
BioRender's stack includes React, Node.js, Express.js, MongoDB, Prisma and Python on AWS, with Terraform, Cloudflare and Datadog, plus PyTorch and TensorFlow for machine learning work.
Yes. Sales is BioRender's largest hiring area, followed by marketing and support, and overall hiring velocity is accelerating across the United States, Ireland and Canada.
BioRender is headquartered in Toronto, Ontario, Canada. It was founded in 2017 and has 201–500 employees.
Other companies in the same industry, closest in size
BioRender's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.